India, May 23 -- What connects Elon Musk, Oprah Winfrey, Kate Winslet and Kim Kardashian? The answer is Ozempic, and now Indian healthtech startups are entering the Ozempic and Mounjaro era.

The diabetes drug, which has quickly gained market share for its effectiveness in weight loss, is becoming a key part of healthtech stacks in India - with Bengaluru-based Healthify becoming the first player to formally introduce GLP-1 drugs for medically-assisted weight loss.

The startup, which raised $20 Mn late last year, has launched HealthifyRx, a companion programme built around the anti-obesity medication and is likely to launch it in the US as well as in India.

For those who have missed the Ozempic and Mounjaro mania, these are classes of dr...